{'output': [['Takeda Pharmaceutical Co Ltd', 'COMP', 'Collaborate', 'Denali Therapeutics', 'COMP'], ['Denali Therapeutics', 'COMP', 'Receive', 'Initial Payment', 'FIN_INSTRUMENT'], ['Denali Therapeutics', 'COMP', 'Responsible', 'Development Activities', 'SECTOR'], ['Denali Therapeutics', 'COMP', 'Eligible', 'Receive', 'Milestone Payments', 'FIN_INSTRUMENT'], ['Denali Therapeutics', 'COMP', 'Collaboration Agreement', 'Develop,Commercialize', '3', 'PRODUCT'], ['Denali Therapeutics', 'COMP', 'Jointly Commercialized', 'Products', 'US, China', 'GPE'], ['Denali Therapeutics', 'COMP', 'Share', 'Global Profits', 'FIN_INSTRUMENT'], ['Takeda Pharmaceutical Co Ltd', 'COMP', 'Exclusive Commercialization Rights', 'All Other Markets', 'GPE'], ['Takeda Pharmaceutical Co Ltd', 'COMP', 'Has', 'Option', 'Co-Develop, Co-Commercialize', '3', 'PRODUCT']]}